Science Applications Inte... (SAIC)
100.02
-2.61 (-2.54%)
At close: Mar 06, 2025, 1:49 PM
Science Applications International Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Cash & Equivalents | 94M | 109M | 106M | 171M | 188M | 237M | 144M | 210M | 195M | 301M | 254M | 736M | 1.59B | 1.37B |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | 72M | -43M | 59M | 37M | 22M | -23M | -10M | -8M | -19M | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 167M | -243M | 129M | -192M | -153M | -132M | 20M | 18M | 15M | 17M | 9M | 79M | 75M | 71M |
| Receivables | 914M | 936M | 1.01B | 962M | 1.1B | 1.05B | 674M | 539M | 635M | 544M | 621M | 691M | 2.16B | 2.07B |
| Inventory | 3M | 152M | 142M | 156M | 143M | 146M | 132M | 152M | 122M | 98M | 119M | 192M | 168M | 116M |
| Other Current Assets | 120M | 81M | 78M | 78M | 59M | 72M | 99M | 81M | 54M | 30M | 60M | 23M | 307M | 315M |
| Total Current Assets | 1.13B | 1.2B | 1.26B | 1.29B | 1.43B | 1.43B | 950M | 901M | 952M | 943M | 994M | 3.08B | 4.21B | 3.87B |
| Property-Plant & Equipment | 243M | 250M | 309M | 344M | 281M | 103M | 61M | 60M | 71M | 59M | 60M | 318M | 348M | 359M |
| Goodwill & Intangibles | 3.75B | 3.92B | 4.04B | 3.92B | 2.85B | 2.92B | 1.04B | 1.06B | 1.08B | 379M | 383M | 2.38B | 2B | 1.88B |
| Total Long-Term Assets | 4.18B | 4.35B | 4.48B | 4.43B | 3.28B | 3.13B | 1.12B | 1.14B | 1.17B | 455M | 453M | 2.8B | 2.46B | 2.36B |
| Total Assets | 5.31B | 5.54B | 5.75B | 5.72B | 4.71B | 4.56B | 2.07B | 2.04B | 2.12B | 1.4B | 1.45B | 5.88B | 6.67B | 6.22B |
| Account Payables | 567M | 624M | 612M | 517M | 527M | 455M | 397M | 329M | 351M | 315M | 337M | 420M | 485M | 1.2B |
| Deferred Revenue | n/a | 48M | 55M | 82M | 41M | -201M | 23M | 13M | 8M | -82M | 3M | 132M | 211M | 511M |
| Short-Term Debt | 77M | 31M | 148M | 68M | 70M | 24M | 41M | 25M | 57M | 32M | 13M | 1.16B | 553M | 3M |
| Other Current Liabilities | 514M | 471M | 592M | 690M | 531M | 405M | 250M | 264M | 280M | 205M | 211M | 1.36B | 1.78B | 540M |
| Total Current Liabilities | 1.16B | 1.13B | 1.35B | 1.27B | 1.13B | 897M | 695M | 615M | 688M | 577M | 564M | 1.79B | 3.02B | 1.74B |
| Long-Term Debt | 2.17B | 2.5B | 2.56B | 2.65B | 2.02B | 2.06B | 983M | 1.02B | 1.01B | 457M | 489M | -157M | 1.42B | 2.34B |
| Other Long-Term Liabilities | 202M | 214M | 160M | 242M | 133M | 102M | 68M | 51M | 41M | 19M | 2M | -91M | 162M | 135M |
| Total Long-Term Liabilities | 2.37B | 2.71B | 2.77B | 2.9B | 2.16B | 2.17B | 1.05B | 1.07B | 1.05B | 476M | 506M | 1.49B | 1.58B | 2.47B |
| Total Liabilities | 3.53B | 3.84B | 4.12B | 4.17B | 3.28B | 3.06B | 1.75B | 1.69B | 1.74B | 1.05B | 1.07B | 3.28B | 4.61B | 4.21B |
| Total Debt | 2.25B | 2.53B | 2.71B | 2.72B | 2.09B | 2.09B | 1.02B | 1.05B | 1.07B | 489M | 502M | 1.32B | 1.97B | 2.34B |
| Common Stock | n/a | 1.69B | 1.62B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 596M | n/a | n/a |
| Retained Earnings | 1.43B | 1.03B | 818M | 627M | 506M | 367M | 323M | 265M | 174M | 116M | 30M | 2.37B | 1.84B | 1.78B |
| Comprehensive Income | 16M | 22M | -37M | -89M | -72M | -14M | 4M | -2M | -9M | -5M | -2M | -2M | -11M | -7M |
| Shareholders Equity | 1.78B | 1.69B | 1.62B | 1.54B | 1.42B | 1.5B | 327M | 354M | 380M | 345M | 377M | 2.6B | 2.06B | 2.01B |
| Total Investments | -28M | 72M | -43M | 59M | 37M | 22M | -23M | -10M | -8M | -19M | n/a | n/a | n/a | n/a |